The following table summarizes the components of stock-based compensation expense recognized in the Company’s condensed consolidated statements of income for the periods indicated:


	Three Months Ended July 31,
	2026		2025

	(in thousands)
Restricted stock	$	12,238	$	10,790
ESPP	210		219
Total stock-based compensation expense	$	12,448	$	11,009


	Shares	Weighted- Average Grant Date Fair Value

	(in thousands, except per share data)
Non-vested, April 30, 2026	1,884	$	70.56
Granted	921	$	67.63
Vested	(827)	$	48.87
Forfeited/expired	(27)	$	66.74
Non-vested, July 31, 2026	1,951	$	78.43

As of July 31, 2026, there were 0.8 million shares outstanding relating to market-based restricted stock units with total unrecognized compensation totaling $47.4 million.

As of July 31, 2026, there was $126.0 million of total unrecognized compensation cost related to all non-vested awards of restricted stock, which is expected to be recognized over a weighted-average period of 2.8 years. During the three months ended July 31, 2026 and 2025, 330,514 shares and 254,047 shares of restricted stock totaling $24.9 million and $18.7 million, respectively, were repurchased by the Company, at the option of employees, to pay for taxes related to the vesting of restricted stock.

During the three months ended July 31, 2026 and 2025, employees purchased 67,843 shares at $59.92 per share and 63,001 shares at $66.00 per share, respectively, under the ESPP. As of July 31, 2026, the ESPP had approximately 1.3 million shares remaining available for future issuance.

During the three months ended July 31, 2025, the Company repurchased (on the open market or through privately negotiated transactions) 145,770 shares of the Company’s common stock for $9.9 million. There were no repurchases of the Company's common stock during the three months ended July 31, 2026.